[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:ebv-infection":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":67,"states":68},"EBV Infection",9,8,[8,16,23,29,35,41,48,54,60],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT03266653","EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection",[12],"Phase 2","RECRUITING","2026-08-26T02:15:28.524219Z","2026-05-05T02:43:28.820567Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05183490","R-MVST Cells for Treatment of Viral Infections",[20],"Phase 1","2026-08-26T02:17:14.343713Z","2026-05-05T02:43:29.726676Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT02532452","Third Party Viral Specific T-cells (VSTs)",[12],"2026-08-26T02:19:13.549512Z","2026-05-05T02:43:28.672557Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06926894","R-MVST Cells for Treatment of Viral Infections in Children and Young Adults",[20],"2026-08-26T02:17:53.433613Z","2026-05-05T02:43:27.623199Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT04013802","TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.",[20],"2026-08-26T02:16:09.452956Z","2026-05-05T02:43:27.168885Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":46,"content_modified":47},"NCT06909110","Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity",[45],"Phase 1\u002FPhase 2","2026-08-26T02:16:15.345907Z","2026-05-05T02:43:27.099634Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT00006518","Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer",[],"2026-08-26T02:17:21.315591Z","2026-05-13T02:55:06.028653Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06908096","Epstein-Barr Virus (EBV) gH\u002FgL\u002Fgp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection",[20],"2026-08-26T02:18:24.494016Z","2026-05-05T02:43:27.924395Z",{"nct_id":61,"title":62,"phases":63,"status":64,"updated_at":65,"content_modified":66},"NCT06027879","Anti-viral T-cell Therapy by Gamma Capture",[45],"ENROLLING_BY_INVITATION","2026-08-26T02:17:35.666428Z","2026-06-16T05:54:08.096276Z",[],[69,73],{"state":70,"count":71,"slug":72},"Maryland",3,"maryland",{"state":74,"count":71,"slug":75},"New York","new-york"]